NAGE FY 2016 Earnings — Niagen Bioscience Inc Revenue & Financial Results | Market Cap Arena

NAGENiagen Bioscience Inc

$393M

FY 2016 Earnings

Healthcare Biotechnology

Income Statement

Revenue

$22M+21.1% YoY

Gross Profit

$10M48.0% margin

Operating Income

-$3M-13.4% margin

Net Income

-$3M-13.5% margin

EPS (Diluted)

$-0.08

Cash Flow

Operating Cash Flow

-$3M

Free Cash Flow

-$5M

Stock-Based Comp.

$1M

Balance Sheet

Total Assets

$20M

Total Liabilities

$10M

Stockholders' Equity

$10M

Cash & Equivalents

$2M

Year-over-Year Comparison

Metric	Current	Year Ago	Change
Revenue	$22M	$18M	+21.1%
Gross Profit	$10M	$8M	+37.9%
Operating Income	-$3M	-$2M	-40.6%
Net Income	-$3M	-$3M	-5.7%